evidence table
Black Seed Oil Blood Pressure Randomized Trial Evidence Table
Structured evidence table for Black Seed Oil Blood Pressure Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Black Seed Oil Blood Pressure Randomized Trial | ) supplementation may offer beneficial effects in modulating various cardiometabolic risk factors, although findings from clinical trials have been inconsistent. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Black Seed Oil Blood Pressure Randomized Trial | Sesame supplementation significantly reduced both systolic and diastolic blood pressure. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Black Seed Oil Blood Pressure Randomized Trial | Further-more, sesame intake was associated with a significant reduction in liver enzyme levels, particularly alanine aminotransferase (ALT). | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
| Black Seed Oil Blood Pressure Randomized Trial | Background Cardiometabolic disorders, such as diabetes, hypertension, dyslipidemia, retinopathy, and non-alcoholic fatty liver disease, present significant health challenges globally. | 4 | Kuo WH (2026) | Integrative Evidence on Sesame Supplementation for Cardiometabolic Risk Factors Relevant to Retinopathy. |
Source documents